C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis

Vascular Medicine

Volumn 13, Issue 1, 2008, Pages 25-28

  Rosenau, Barbara J ^a   Costenbader, Karen H ^a   Schur, Peter H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Autoantibodies; C reactive protein

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; C REACTIVE PROTEIN ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AGED; ATHEROSCLEROSIS; AUTOANTIBODIES; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED;

EID: 42649105083     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X07084912     Document Type: Article

References (14)

1. Reeves, WH, Richards, HB, Satoh, M. Autoantibodies. In: Lahita, RG, Chiorazzi, N, Reeves, WH. (eds). Textbook of the autoimmune diseases. Lippincott, 2000: 81-100.
2. Rosenau, BJ, Schur, PH. Antibody to serum Amyloid A. J Autoimmun 2004; 23: 179-182.
3. Bell, SA, Faust, H, Schmid, A, Meurer, M. Auto antibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune disease. Clin Exp Immunol 1998; 113: 327-332.
4. Sjowall, C, Eriksson, P, Almer, S, Skogh, T. Auto antibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J Autoimmun 2002; 19: 155-160.
5. Rosenau, BJ, Schur, PH. Antibodies to C reactive protein. Ann Rheum Dis 2006; 65: 674-676.
6. Libby, P, Ridker, PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004; 116(suppl 6A): 9S-16S.
7. Albert, MA, Danielson, E, Rifai, N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001; 286: 64-70.
8. Whicker, JT, Ritchie, RF, Johnson, AM, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994: 40; 934-938.
9. Hansson, GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
10. Fischer, LM, Schlienger, RG, Matter, C, et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004; 93: 198-200.
11. Wilson, AM, Ryan, MC, Boyle, AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 2006; 106: 291-297.
12. Eaton, RB, Schnneider, G, Schur, PH. Enzyme immunoassay for antibodies to nDNA: specificity and quality of antibodies. Arthritis Rheum 1983; 26: 52-62.
13. Hoch, S, Schur, PH, Schwaber, J. Frequency of anti-DNA antibody producing cells from normals and patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1983; 27: 28-37.
14. Tan, EM, Feltkamp, TE, Smolen, JS, et al. Range of antinuclear antibodies in 'healthy' individuals. Arthritis Rheum 1997; 40: 1601-1611.